Adagene Inc   Report issue

For profit Phase 1 Phase 2
Founded: Suzhou China (2012)

Organization Overview

First Clinical Trial
2018
NCT03707093
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Adagene Inc | Adagene (Suzhou) Limited